NCT02641197 - Vascular Reactivity Assessment by the AngioDefender Device -- A Precision Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 6, 2016

Primary Completion Date

May 19, 2016

Study Completion Date

May 19, 2016

Conditions

Cardiovascular Diseases

Interventions

DEVICE

AngioDefender

"Repeatability will be assessed by repeat AngioDefender (AD) testing of the same subject 1 hour apart, using the same AD device and operator.~Reproducibility will be assessed by comparing FMD scores obtained for the same subject, but using different AD devices and operators."

Trial Locations (2)

N6A 5A5

University of Western Ontario, London

N9C 3Z4

Hotel-Dieu Grace Healthcare, Windsor